Synthesis of (-)-homogalanthamine from naltrexone

Journal of Organic Chemistry

Volumn 76, Issue 7, 2011, Pages 2257-2260

  Yamamoto, Naoshi ^a,b   Fujii, Hideaki ^a   Imaide, Satomi ^a   Hirayama, Shigeto ^a   Nemoto, Toru ^a   Inokoshi, Junji ^a   Tomoda, Hiroshi ^a   Nagase, Hiroshi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; GROB FRAGMENTATION; KEY REACTIONS; NALTREXONE; SYNTHESIS FEATURES; TOTAL YIELD;

CROWN ETHERS;

SYNTHESIS (CHEMICAL);

CHOLINESTERASE INHIBITOR; GALANTAMINE; HOMOGALANTHAMINE; NALTREXONE; UNCLASSIFIED DRUG;

ARTICLE; CATALYST; CHLORINATION; DEHYDROGENATION; DESULFURIZATION; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ELIMINATION REACTION; FRAGMENTATION REACTION; INHIBITION KINETICS; STEREOCHEMISTRY;

CROWN ETHERS; GALANTAMINE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, MU;

EID: 79953227003     PISSN: 00223263     EISSN: 15206904     Source Type: Journal    
DOI: 10.1021/jo1022487     Document Type: Article

References (49)

1. Martin, S. F. In The Alkaloids; Brossi, A., Ed.; Academic Press: New York, 1987; Vol. 30, pp 251 - 376.
2. Hoshino, O. In The Alkaloids; Cordell, G. A., Ed.; Academic Press: New York, 1998; Vol. 51, pp 323 - 424.
3. Sramek, J. J.; Frackiewicz, E. J.; Cutler, N. R. Expert Opin. Invest. Drugs 2000, 9, 2393
4. Lilienfeld, S. CNS Drug Rev. 2002, 8, 159
5. Popa, R. V.; Pereira, E. F. R.; Lopes, C.; Maelicke, A.; Albuquerque, E. X. J. Mol. Neurosci. 2006, 30, 227
6. Jia, P.; Sheng, R.; Zhang, J.; Fang, L.; He, Q.; Yang, B.; Hu, Y. Eur. J. Med. Chem. 2009, 44, 772
7. Marco-Contelles, J.; Carreiras, M. C.; Rodríguez, C.; Villarroya, M.; García, A. G. Chem. Rev. 2006, 106, 116
8. Hu, X.-D.; Tu, Y. Q.; Zhang, E.; Gao, S.; Wang, S.; Wang, A.; Fan, C.-A.; Wang, M. Org. Lett. 2006, 8, 1823
9. Node, M.; Kodama, S.; Hamashima, Y.; Katoh, T.; Nishide, K.; Kajimoto, T. Chem. Pharm. Bull. 2006, 54, 1662
10. Satcharoen, V.; McLean, N. J.; Kemp, S. C.; Camp, N. P.; Brown, R. C. D. Org. Lett. 2007, 9, 1867
11. Tanimoto, H.; Kato, T.; Chida, N. Tetrahedron Lett. 2007, 48, 6267
12. Ishikawa, T.; Kudo, K.; Kuroyabu, K.; Uchida, S.; Kudoh, T.; Saito, S. J. Org. Chem. 2008, 73, 7498
13. Reddy, J. M.; Kumar, K. V.; Raju, V.; Bhaskar, B. V.; Himabindu, V.; Bhattacharya, A.; Sundaram, V.; Banerjee, R.; Reddy, G. M.; Bandichhor, R. Synth. Commun. 2008, 38, 2138
14. Magnus, P.; Sane, N.; Fauber, B. P.; Lynch, V. J. Am. Chem. Soc. 2009, 131, 16045
15. Chang, J. K.; Kang, H.-U.; Jung, I.-H.; Cho, C.-G. Org. Lett. 2010, 12, 2016
16. Pelish, H. E.; Westwood, N. J.; Feng, Y.; Kirchhausen, T.; Shair, M. D. J. Am. Chem. Soc. 2001, 123, 6740
17. Chandrasekhar, S.; Sailu, D. B. M.; Kotamraju, S. Tetrahedron Lett. 2009, 50, 4882
18. Rao, V. K.; Rao, A. J.; Reddy, S. S.; Raju, C. N.; Rao, P. V.; Ghosh, S. K. Eur. J. Med. Chem. 2010, 45, 203
19. Lewin, A. H.; Szewczyk, J.; Wilson, J. W.; Carroll, F. I. Tetrahedron 2005, 61, 7144
20. Bartolucci, C.; Haller, L. A.; Jordis, U.; Fels, G.; Lamba, D. J. Med. Chem. 2010, 53, 745
21. Franck, R. D.; Johnson, W. S. Tetrahedron Lett. 1963, 545
22. Grob, C. A.; Schiess, P. W. Angew. Chem., Int. Ed. 1967, 6, 1
23. Yoshimitsu, T.; Yanagiya, M.; Nagaoka, H. Tetrahedron Lett. 1999, 40, 5215
24. Prantz, K.; Mulzer, J. Chem. Rev. 2010, 110, 3741
25. Sawa, Y. K.; Toda, H. Tetrahedron Lett. 1968, 24, 6185
26. Nemoto, T.; Fujii, H.; Nagase, H. Tetrahedron Lett. 2007, 48, 7413
27. Nemoto, T.; Fujii, H.; Narita, M.; Miyoshi, K.; Nakamura, A.; Suzuki, T.; Nagase, H. Bioorg. Med. Chem. 2008, 16, 4304
28. Smith, D. H., Jr. U.S. Patent 4478840, 1984.
29. Hydroxy-directed reduction of α- or β-hydroxy ketones: Saksena, A. K.; Mangiaracina, P. Tetrahedron Lett. 1983, 24, 273
30. Turnbull, M. D.; Hatter, G.; Ledgerwood, D. E. Tetrahedron, Lett. 1984, 25, 5449
31. Zhang, H.-C.; Daves, G. D., Jr. J. Org. Chem. 1992, 57, 4690
32. 3 may also be important.
33. MaloneyHuss, K. E.; Portoghese, P. S. J. Org. Chem. 1990, 55, 2957
34. Browm, H. C.; Krishnamurthy, S. J. Chem. Soc., Chem. Commun. 1972, 868
35. Krishnamurthy, S.; Brown, H. C. J. Org. Chem. 1979, 44, 3678
36. Welch, S. C.; Rao, A. S. C. P.; Lyon, J. T.; Assercq, J.-M. J. Am. Chem. Soc. 1983, 105, 252
37. Nagase, H.; Nemoto, T.; Matsubara, A.; Saito, M.; Yamamoto, N.; Osa, Y.; Hirayama, S.; Nakajima, M.; Nakao, K.; Mochizuki, H.; Fujii, H. Bioorg. Med. Chem. Lett. 2010, 20, 6302
38. Mohacsi, E.; Hayes, T. J. Heterocycl. Chem. 1982, 19, 901
39. The addition of 15-crown-5 exhibited a crucial effect for the smooth progression of the fragmentation. See the Supporting Information for details.
40. Saegusa oxidation of 4 also provided 17. See the Supporting Information for details.
41. White, J. D.; Shin, H.; Kim, T.-S.; Cutshall, N. S. J. Am. Chem. Soc. 1997, 119, 2404
42. Yoshida, Y.; Mohri, K.; Isobe, K.; Itoh, T.; Yamamoto, K. J. Org. Chem. 2009, 74, 6010
43. Overman, L. E. Angew. Chem., Int. Ed. 1984, 23, 579
44. Lim, C.; Baek, D. J.; Kim, D.; Youn, S. W.; Kim, S. Org. Lett. 2009, 11, 2583
45. Knipmeyer, L. L.; Rapoport, H. J. Med. Chem. 1985, 28, 461
46. Fujii, H.; Watanabe, A.; Nemoto, T; Narita, M.; Miyoshi, K.; Nakamura, A.; Suzuki, T.; Nagase, H. Bioorg. Med. Chem. Lett. 2009, 19, 438.
47. Node, M.; Kumar, K.; Nishide, K.; Ohsugi, S.; Miyamoto, T. Tetrahedron Lett. 2001, 42, 9207
48. Recently, a demethylation with dodecylthiolate was reported. Chae, J. Arch. Pharm. Res. 2008, 31, 305
49. In general, derivatives with a phenolic OH group show higher affinities for the opioid receptors than the corresponding compounds with a OMe group.